77 related articles for article (PubMed ID: 23517228)
1. Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?
Gandhi S; Narula N; Gandhi S; Marshall JK; Farkouh ME
J Gastroenterol Hepatol; 2013 Jun; 28(6):931-6. PubMed ID: 23517228
[TBL] [Abstract][Full Text] [Related]
2. Positive predictive value of fecal occult blood testing in persons taking warfarin.
Bini EJ; Rajapaksa RC; Weinshel EH
Am J Gastroenterol; 2005 Jul; 100(7):1586-92. PubMed ID: 15984986
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test performance indicators in warfarin-treated patients.
Kershenbaum A; Lavi I; Rennert G; Almog R
Dis Colon Rectum; 2010 Feb; 53(2):224-9. PubMed ID: 20087099
[TBL] [Abstract][Full Text] [Related]
4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
5. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.
Sawhney MS; McDougall H; Nelson DB; Bond JH
Dig Dis Sci; 2010 Jun; 55(6):1637-42. PubMed ID: 20195757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
9. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
10. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
11. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
13. Warfarin Use During Fecal Occult Blood Testing: A Meta-Analysis.
Ashraf I; Paracha S; Paracha SU; Arif M; Choudhary A; Godfrey JD; Clark RE; Abdullah O; Matteson ML; Puli SR; Ibdah JA; Dabbagh O; Bechtold ML
Gastroenterology Res; 2012 Apr; 5(2):45-51. PubMed ID: 27785179
[TBL] [Abstract][Full Text] [Related]
14. Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.
Konrad G; Katz A
Can Fam Physician; 2012 Sep; 58(9):939-48. PubMed ID: 22972722
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Lieberman N; Klang S; Niv Y
Am J Gastroenterol; 2009 Apr; 104(4):933-8. PubMed ID: 19293792
[TBL] [Abstract][Full Text] [Related]
16. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
[TBL] [Abstract][Full Text] [Related]
17. Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?
Imperiale TF
Am J Gastroenterol; 2010 Sep; 105(9):2036-9. PubMed ID: 20818354
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant or aspirin treatment does not affect the positive predictive value of an immunological fecal occult blood test in patients undergoing colorectal cancer screening: results from a nested in a cohort case-control study.
Mandelli G; Radaelli F; Paggi S; Terreni N; Gola G; Gramegna M; Bonaffini A; Terruzzi V
Eur J Gastroenterol Hepatol; 2011 Apr; 23(4):323-6. PubMed ID: 21389863
[TBL] [Abstract][Full Text] [Related]
20. Fecal occult blood testing for colorectal cancer screening: use the finger.
Burke CA; Tadikonda L; Machicao V
Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
